MeSH D005356 - fibromyalgia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Pregabalin | Pregabalin |  | 2019-07-19 |  |  |
| Mylan | Pregabalin | Pregabalin |  | 2019-09-20 |  |  |
| Pregabalin | Pregabalin Mylan |  | 2015-06-24 |  |  | |
| Pregabalin | Pregabalin Mylan Pharma |  | 2015-06-25 |  |  | |
| Cipla | Pregabalin | Pregabalin |  | 2019-07-19 |  |  |
| Lupin Research | Pregabalin | Pregabalin |  | 2022-05-03 |  |  |
| Sandoz | Pregabalin | Pregabalin Sandoz |  | 2015-06-19 |  |  |
| Pregabalin | Pregabalin Sandoz GmbH |  | 2015-06-19 |  |  | |
| Dr Reddys Laboratories | Pregabalin | Pregabalin |  | 2019-07-19 |  |  |
| Rising Pharmaceuticals | Pregabalin | Pregabalin |  | 2019-07-19 |  |  |
| Zydus Therapeutics | Pregabalin | Pregabalin |  | 2022-12-09 |  |  |
| Sun Pharmaceutical Industries | Pregabalin | Pregabalin |  | 2019-11-29 |  |  |
| Alembic Pharmaceuticals | Pregabalin | Pregabalin |  | 2019-07-19 |  |  |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
63%19/30
Phase 2
45%25/55
Phase 3
38%12/32
Approved: 1Overall Success rate: 11%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use